SPI.L
Spire Healthcare Group plc

Healthcare · Medical Care Facilities · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

194.04M USD

Market Cap

1.33B USD

Margin of Safety

-584.0%

Intrinsic / Market Ratio

0.15×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

-97.67M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

362.49M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

317.30M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

194.04M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

194.04M USD

from the sum above

Market Cap

1.33B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.15×

the ratio the screener ranks by; Margin of Safety -584.0% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: -97.67M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)1.63B USD
−②Net Debt Today1.73B USD
+③Growth Value0 USD
=Value-97.67M USD

EPV of the Operations (NOPAT over WACC)

1.63B USD

Net debt today

-1.73B USD

Growth Value

0 USD

Value

-97.67M USD

①EPV (earnings power value)

1.63B USD

②Net Debt Today

1.73B USD

③Growth Value

0 USD

Market value

Market Cap1.33B USD

The price on the date above times the shares.

Value vs market

Margin of Safety—

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 362.49M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE106.99M USD
+②Equity at Year 15, Today255.51M USD
=Value362.49M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROE on new investment rising to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

106.99M USD

②Equity at Year 15, Today

255.51M USD

Market value

Market Cap1.33B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-266.2%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 317.30M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF1.17B USD
+②Invested Capital at Year 15, Today877.55M USD
−③Net Debt Today1.73B USD
=Value317.30M USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment rising to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

1.17B USD

②Invested Capital at Year 15, Today

877.55M USD

③Net Debt Today

1.73B USD

Market value

Market Cap1.33B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-318.3%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 8.48%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.93×Market Risk Premium 6.00%= 10.09%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 1.89M USDPretax Income 25.07M USD= 7.53%

The tax the interest saves.

Interest Expense =EBIT 164.60M USD−Pretax Income 25.07M USD= 139.52M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 139.52M USDTotal Debt 1.77B USD×(1 − Tax Rate for WACC 7.53%)= 7.27%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 1.77B USDMarket Cap + Total Debt 1.33B USD + 1.77B USD= 57.20%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 42.80%×Cost of Equity 10.09%+Debt Weight 57.20%×Cost of Debt 7.27%= 8.48%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2025-12-31.

Total Assets 3.20B USD − Total Liabilities 2.20B USD = Book Value Today 1.00B USD

Total Debt 1.77B USD − Cash and Short-Term Investments 46.78M USD = Net Debt Today 1.73B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-0.8%at most 5%passes400,550,322 / 403,814,470
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets9.5%at least -10.0%passes(326.50M USD − 22.11M USD) ÷ 3.20B USD
Price to bookMarket Cap ÷ Book Value Today1.32×at most 3×passes1.33B USD ÷ 1.00B USD
Operating marginOperating Income ÷ Revenue7.5%above 10.0%does not pass160.69M USD ÷ 2.13B USD
Revenue growthRevenue ÷ Revenue a Year Before − 112.2%above 10.0%passes2.13B USD / 1.90B USD
Net cash(Cash − Total Debt) ÷ Market Cap-130.1%above -30%does not pass(46.78M USD − 1.77B USD) ÷ 1.33B USD
Operating efficiencyOperating Income ÷ Gross Profit16.6%above 25.0%does not pass160.69M USD ÷ 965.35M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

247.75 GBp

Enterprise value

2.27B GBP

the provider's own figure

EV / EBITDA

11.84×

Price / book

1.33×

the provider's book

Price / earnings

—

Return on equity

-0.2%

the provider's figure, not this page's

Profit margin

-0.1%

Revenue growth

-0.5%

Analyst target, mean

264.51 GBp

Analysts

4

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

1.45B1.73B1.90B2.13B

Gross profit

649.76M795.65M858.71M965.35M

Operating income

111.51M161.63M156.89M160.69M

EBITDA

operating income before depreciation and amortisation

226.52M292.79M312.66M325.83M

Pretax income

4.71M44.10M48.11M25.07M

Net income

10.38M34.80M31.91M22.11M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

7.45M35.42M22.53M18.24M

R&D

————
Balance sheet, year end

Total assets

2.61B2.92B2.94B3.20B

Total liabilities

1.73B1.98B2.01B2.20B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

882.20M943.13M940.11M1.00B

Total debt

1.44B1.60B1.61B1.77B

Cash and equivalents

89.55M63.22M51.75M46.78M

Net PP&E

fixed assets after depreciation

1.91B2.06B2.09B2.28B

Working capital

current assets less current liabilities

-76.51M-123.64M-146.22M-168.91M
Cash flow

Operating cash flow

219.16M274.69M296.08M326.50M

Capital expenditure

paid out, so below zero

-105.84M-107.58M-140.82M-105.82M

Depreciation and amortisation

118.15M132.06M140.94M161.23M

Free cash flow

operating cash flow plus capital expenditure

113.32M167.11M155.26M220.68M